Skip to content

Role of Patient Selection for Pancreatic Resections

Importance of Patient Characteristics in Identifying and Selecting Patients Suitable for Pancreatic Resection

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06390891
Acronym
PatSelPanc
Enrollment
86073
Registered
2024-04-30
Start date
2010-01-01
Completion date
2018-12-31
Last updated
2024-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreas Disease

Keywords

Specialization, Pancreatic Surgery, Resection, Volume-Outcome-Relationship

Brief summary

Pancreatic surgery is complicated and risky, especially for pancreatic cancer. It's been noticed that having these surgeries done at specialized centers can lead to better outcomes and survival rates. However, factors like patient selection and hospital conditions also play an important role. Some studies show that more surgeries done at a hospital might not always mean better results, as the type of patients and procedures can vary. To understand this better, the present study compared outcomes and patient characteristics between high-volume pancreatic centers and others.

Detailed description

The study utilized German nationwide administrative data (diagnosis-related group statistics) spanning from 2010 to 2018. Persons who underwent pancreatic resections during this period were included, with exclusions for certain criteria like underage and type of procedure. Various factors including patient demographics, diagnoses, procedures, and comorbidities were analyzed to assess in-hospital mortality rates. High-volume pancreatic centers (HVPCs) were identified as those performing at least 50 procedures annually. Statistical analyses included comparing crude and adjusted mortality rates and assessing patient characteristics between HVPCs and non-HVPCs. Models were adjusted for multiple variables, and methods like the Cochran-Armitage trend test and mixed models were employed. Additionally, the study investigated how differences in patient characteristics between HVPCs and non-HVPCs affected mortality rates.

Interventions

OTHERPersons with pancreatic resection in a hospital with at least 50 pancreatic resections annually (observational),

Persons that have undergone a pancreatic resection at a hospital with at least 50 pancreatic resections annually (observational)

OTHERPersons with pancreatic resection in a hospital not performing at least 50 pancreatic resections annually (observational),

Persons that have undergone a pancreatic resection at a hospital with not at least 50 pancreatic resections annually (observational)

Sponsors

Medizinische Hochschule Brandenburg Theodor Fontane
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* partial or total pancreatic resections between 2010 and 2018

Exclusion criteria

* childhood (\<18 years) * subjects with a pancreatic transplantation procedure * missing information on age or gender

Design outcomes

Primary

MeasureTime frameDescription
In-hospital mortality30 daysDeath

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026